🇦🇪 Radicava in United Arab Emirates

MOH authorised Radicava on 5 May 2017

Marketing authorisation

MOH — authorised 5 May 2017

  • Marketing authorisation holder: MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA INC
  • Status: likely_approved

Radicava in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in United Arab Emirates

Frequently asked questions

Is Radicava approved in United Arab Emirates?

Yes. MOH authorised it on 5 May 2017.

Who is the marketing authorisation holder for Radicava in United Arab Emirates?

MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA INC holds the UAE marketing authorisation.